Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Wilkinson, M. Nieto (1993)
Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts.Methods in enzymology, 225
M. Metsäranta, M. Metsäranta, David Toman, David Toman, B. Crombrugghe, B. Crombrugghe, Eero Vuorio, Eero Vuorio (1991)
Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs.Biochimica et biophysica acta, 1089 2
A. Abuin, A. Bradley (1996)
Recycling selectable markers in mouse embryonic stem cellsMolecular and Cellular Biology, 16
L. Bridgewater, V. Lefebvre, B. Crombrugghe (1998)
Chondrocyte-specific Enhancer Elements in the Col11a2Gene Resemble the Col2a1 Tissue-specific Enhancer*The Journal of Biological Chemistry, 273
Stefan Mundlos, Björn Olsen (1997)
Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development‐matrix components and their homeostasisThe FASEB Journal, 11
R. Behringer, M. Finegold, R. Cate (1994)
Müllerian-inhibiting substance function during mammalian sexual developmentCell, 79
Donald Bell, K. Leung, S. Wheatley, L. Ng, Sheila Zhou, Kam‐Wing Ling, M. Sham, P. Koopman, P. Tam, K. Cheah (1997)
SOX9 directly regulates the type-ll collagen geneNature Genetics, 16
J. Foster, M. Dominguez-Steglich, S. Guioli, C. Kwok, P. Weller, M. Stevanović, J. Weissenbach, S. Mansour, Ian Young, P. Goodfellow, J. Brook, A. Schafer (1994)
Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related geneNature, 372
C. Kwok, Weller Pa, Silvana Guioli, Foster Jw, Sahar Mansour, O. Zuffardi, Punnett Hh, Dominguez-Steglich Ma, Brook Jd, Young Id (1995)
Mutations in SOX9, the gene responsible for Campomelic dysplasia and autosomal sex reversal.American journal of human genetics, 57 5
B. Hall, Stuart Newman (1991)
Cartilage Molecular Aspects
V. Lefebvre, Wendong Huang, V. Harley, P. Goodfellow, B. Crombrugghe (1997)
SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen geneMolecular and Cellular Biology, 17
S. Oberlender, R. Tuan (1994)
Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis.Development, 120 1
R. Stockwell (1979)
Biology of cartilage cells
Stefan Mundlos, Björn Olsen (1997)
Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development‐transcription factors and signaling pathways 1The FASEB Journal, 11
T. Wagner, J. Wirth, Jobst Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F. Bricarelli, Jürgen Keutel, E. Hustert, U. Wolf, N. Tommerup, W. Schempp, G. Scherer (1994)
Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9Cell, 79
A. Erlebacher, E. Filvaroff, S. Gitelman, R. Derynck (1995)
Toward a molecular understanding of skeletal developmentCell, 80
R. Widelitz, T. Jiang, B. Murray, C. Chuong (1993)
Adhesion molecules in skeletogenesis: II. Neural cell adhesion molecules mediate precartilaginous mesenchymal condensations and enhance chondrogenesisJournal of Cellular Physiology, 156
H. Takahashi, I. Sando, H. Masutani (1992)
Temporal bone histopathological findings in campomelic dysplasiaThe Journal of Laryngology & Otology, 106
B. Hogan, F. Costantini, E. Lacy (1986)
Manipulating the mouse embryo: A laboratory manual
J. Kent, S. Wheatley, J. Andrews, A. Sinclair, P. Koopman (1996)
A male-specific role for SOX9 in vertebrate sex determination.Development, 122 9
P. Mountford, B. Zevnik, A. Duwel, J. Nichols, Meng Li, C. Dani, M. Robertson, I. Chambers, Austin Smith (1994)
Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression.Proceedings of the National Academy of Sciences of the United States of America, 91 10
V. Glumoff, M. Savontaus, Janne Vehanen, E. Vuorio (1994)
Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes.Biochimica et biophysica acta, 1219 3
Qi Zhao, H. Eberspaecher, V. Lefebvre, B. Crombrugghe (1997)
Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesisDevelopmental Dynamics, 209
E. Robertson (1987)
Teratocarcinomas and embryonic stem cells : a practical approach
R. Cancedda, F. Cancedda, P. Castagnola (1995)
Chondrocyte differentiation.International review of cytology, 159
M. Hovmöller, A. Osuna, O. Eklöf, K. Fredga, A. Hjerpe, J. Linsten, M. Ritzén, V. Stanescu, N. Svenningsen (2009)
Camptomelic dwarfism. A genetically determined mesenchymal disorder combined with sex reversal.Hereditas, 86 1
E. Wright, Murray Hargrave, J. Christiansen, Leanne Cooper, J. Kun, T. Evans, U. Gangadharan, A. Greenfield, P. Koopman (1995)
The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryosNature Genetics, 9
Sara Silva, A. Hacker, V. Harley, P. Goodfellow, A. Swain, R. Lovell-Badge (1996)
Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birdsNature Genetics, 14
L. Ng, S. Wheatley, G. Muscat, John Conway-Campbell, J. Bowles, E. Wright, Donald Bell, P. Tam, K. Cheah, P. Koopman (1997)
SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse.Developmental biology, 183 1
K. Elima, M. Metsäranta, J. Kallio, M. Perälä, I. Eerola, S. Garofalo, B. Crombrugghe, E. Vuorio (1992)
Specific hybridization probes for mouse α2(IX) and α1(X) collagen mRNAsBiochimica et Biophysica Acta, 1130
Chondrogenesis results in the formation of cartilages, initial skeletal elements that can serve as templates for endochondral bone formation. Cartilage formation begins with the condensation of mesenchyme cells followed by their differentiation into chondrocytes. Although much is known about the terminal differentiation products that are expressed by chondrocytes 1,2,3 , little is known about the factors that specify the chondrocyte lineage 4,5,6 . SOX9 is a high-mobility-group (HMG) domain transcription factor that is expressed in chondrocytes and other tissues 7,8,9,10,11,12 . In humans, SOX9 haploinsufficiency results in campomelic dysplasia, a lethal skeletal malformation syndrome, and XY sex reversal 7,13,14,15,16 . During embryogenesis, Sox9 is expressed in all cartilage primordia and cartilages, coincident with the expression of the collagen α1(II) gene (Col2a1; refs 8,11, 12). Sox9 is also expressed in other tissues, including the central nervous and urogenital systems 8,9,10,11,12 . Sox9 binds to essential sequences in the Col2a1 and collagen α2(XI) gene (Col11a2) chondrocyte-specific enhancers and can activate these enhancers in non-chondrocytic cells 17,18,19 . Here, Sox9 is identified as a regulator of the chondrocyte lineage. In mouse chimaeras, Sox9 -/- cells are excluded from all cartilages but are present as a juxtaposed mesenchyme that does not express the chondrocyte-specific markers Col2a1, Col9a2, Col11a2 and Agc. This exclusion occurred cell autonomously at the condensing mesenchyme stage of chondrogenesis. Moreover, no cartilage developed in teratomas derived from Sox9 -/- embryonic stem (ES) cells. Our results identify Sox9 as the first transcription factor that is essential for chondrocyte differentiation and cartilage formation.
Nature Genetics – Springer Journals
Published: May 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.